MenQuadfi
MenQuadfi is a quadrivalent meningococcal conjugate vaccine designed to protect against invasive disease caused by Neisseria meningitidis serogroups A, C, W, and Y. It is produced by Sanofi Pasteur and is used to reduce the risk of meningococcal disease in individuals aged 2 years and older.
The vaccine is a protein-conjugate formulation. The polysaccharide capsules of the four meningococcal serogroups are covalently
Indications and usage vary by region, but MenQuadfi is generally indicated for active immunization to prevent
Safety considerations include common reactions such as pain at the injection site, redness, swelling, fever, and
See also: meningococcal disease, MenACWY vaccines, Sanofi Pasteur.